Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03455465 · ClinicalTrials.gov registry record
Using Rapid Cycle Trials to Increase Patient Engagement in the Community Health Worker Program in the Emergency Department
A clinical trial of Patient Engagement; Community Health Workers, sponsored by NYU Langone Health.
- Completed
- Registry status
- 2,314
- Enrollment target
- 1
- Study location
NCT03455465: Completed study of Patient Engagement; Community Health Workers, sponsored by NYU Langone Health.
NCT03455465 is a study of Patient Engagement; Community Health Workers that has completed, run by NYU Langone Health. The registered enrollment target is 2,314 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03455465, a study of Patient Engagement; Community Health Workers, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 2,314 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is evaluating the effectiveness of the post-discharge program facilitated by the Community Health Worker program in the Emergency Department at NYU Langone Health Hospital - Brooklyn and testing different strategies to increase patient engagement in the program.
Primary Outcome
Number of services (emergency department visits, etc.) utilized by the patient.
Conditions Studied
Interventions
- OTHER Community Health Worker Assessment
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,314 participants |
| Start Date | 2018-02-26 |
| Est. Completion | 2018-11-27 |
What the finished NCT03455465 record still lists
NCT03455465 is an observational study that tracks outcomes without assigning an intervention. Its 2,314 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Patient Engagement; Community Health Workers appearing as the primary indexed condition, and to 1 intervention - of which Community Health Worker Assessment is the first listed.
NCT03455465 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03455465 about?
NCT03455465 is a clinical study titled "Using Rapid Cycle Trials to Increase Patient Engagement in the Community Health Worker Program in the Emergency Department". This study is evaluating the effectiveness of the post-discharge program facilitated by the Community Health Worker program in the Emergency Department at NYU Langone Health Hospital - Brooklyn and testing different strategies to increase patient engagement in the program.
What is the current status of trial NCT03455465?
This trial is currently completed. The enrollment target is 2,314 participants. The study started on 2018-02-26. Estimated completion is 2018-11-27.
What conditions does trial NCT03455465 study?
This clinical trial studies the following conditions: Patient Engagement; Community Health Workers.
What interventions are being tested in trial NCT03455465?
The interventions under investigation include: Community Health Worker Assessment (OTHER).
Who is sponsoring clinical trial NCT03455465?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03455465 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05485961 · 2,310 participants · Phase 2
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
- NCT06824194 · 2,320 participants · Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI